Gilead Sciences
GILD
#117
Rank
NZ$276.93 B
Marketcap
NZ$223.12
Share price
0.62%
Change (1 day)
29.54%
Change (1 year)

EPS for Gilead Sciences (GILD)

EPS in 2025 (TTM): NZ$11.73

According to Gilead Sciences's latest financial reports the company's current EPS (TTM) is NZ$11.61. In 2024 the company made an earnings per share (EPS) of NZ$0.64 a decrease over its 2023 EPS that were of NZ$7.71.

EPS history for Gilead Sciences from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$11.731721.29%
2024NZ$0.64-91.65%
2023NZ$7.7123.98%
2022NZ$6.22-25.86%
2021NZ$8.394850%
2020NZ$0.17-97.64%
2019NZ$7.190.9%
2018NZ$7.1218.71%
2017NZ$6.00-64.88%
2016NZ$17.08-18.45%
2015NZ$20.9555.28%
2014NZ$13.49296.02%
2013NZ$3.4117.89%
2012NZ$2.89

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$18.88 62.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$2.30-80.15%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$4.05-65.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$39.02 236.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$24.29 109.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$14.97 28.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
NZ$9.29-20.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
NZ$26.22 125.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$12.39 6.72%๐Ÿ‡บ๐Ÿ‡ธ USA